Cencora (COR) completed the acquisition of Retina Consultants of America for $4.4 billion in cash, subject to a customary post-closing price adjustment.
Fiscal 2025 adjusted earnings guidance was boosted to the range of $15.15 to $15.45 a share from $14.80 to $15.10 to reflect the acquisition, Cencora said Thursday in a statement.
The company acquired 85% in RCA, while some RCA physicians and managers retained a minority stake.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。